ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04610	Complement and coagulation cascades	9/77	79/7206	1.27029620342e-07
ko04380	Osteoclast differentiation	7/77	134/7206	0.00053516326966
ko00643	Styrene degradation	2/77	4/7206	0.000666929802919
ko00670	One carbon pool by folate	3/77	20/7206	0.00117341185753
ko05100	Bacterial invasion of epithelial cells	5/77	99/7206	0.00400060076311
ko05146	Amoebiasis	5/77	99/7206	0.00400060076311
ko05020	Prion diseases	3/77	40/7206	0.00872715084913
ko00980	Metabolism of xenobiotics by cytochrome P450	3/77	40/7206	0.00872715084913
ko05130	Pathogenic Escherichia coli infection	4/77	77/7206	0.00905142154653
ko05131	Shigellosis	4/77	82/7206	0.0112407372453
ko04216	Ferroptosis	3/77	44/7206	0.0113480264395
ko00660	C5-Branched dibasic acid metabolism	1/77	2/7206	0.0212583661202
ko05410	Hypertrophic cardiomyopathy (HCM)	4/77	100/7206	0.0218373604512
ko04977	Vitamin digestion and absorption	2/77	22/7206	0.0226747369641
ko04611	Platelet activation	5/77	163/7206	0.0298263174411
ko04640	Hematopoietic cell lineage	3/77	64/7206	0.030687572658
ko00040	Pentose and glucuronate interconversions	2/77	26/7206	0.0310398660388
ko05164	Influenza A	5/77	167/7206	0.0326398753688
ko05418	Fluid shear stress and atherosclerosis	5/77	173/7206	0.0371638489403
ko05014	Amyotrophic lateral sclerosis (ALS)	3/77	74/7206	0.0442921835625
ko04932	Non-alcoholic fatty liver disease (NAFLD)	5/77	182/7206	0.0446451247638
ko01524	Platinum drug resistance	3/77	76/7206	0.0473199418227
ko00350	Tyrosine metabolism	2/77	33/7206	0.0480784743613